EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

Proceedings of the National Academy of Sciences
August 25, 2004
Cited by 4,344


Related Papers

No related papers found

Powered by citation graph analysis